PMC:7696151 / 24473-24665 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"707","span":{"begin":139,"end":142},"obj":"Species"},{"id":"718","span":{"begin":31,"end":34},"obj":"Chemical"},{"id":"729","span":{"begin":85,"end":100},"obj":"Disease"}],"attributes":[{"id":"A707","pred":"tao:has_database_id","subj":"707","obj":"Tax:11103"},{"id":"A718","pred":"tao:has_database_id","subj":"718","obj":"MESH:D006886"},{"id":"A729","pred":"tao:has_database_id","subj":"729","obj":"MESH:D017119"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"It was seen that a low dose of HCQ (100 mg twice weekly) prevented the recurrence of Porphyria Tarda and reduced the viral response during HCV therapy, including ribavirin and interferon [45]."}

{"project":"LitCovid-sentences","denotations":[{"id":"T170","span":{"begin":0,"end":192},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"It was seen that a low dose of HCQ (100 mg twice weekly) prevented the recurrence of Porphyria Tarda and reduced the viral response during HCV therapy, including ribavirin and interferon [45]."}